Intranasal Dexmedetomidine: Clinical Trials

2 trials for Intranasal Dexmedetomidine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 unknown. 1 Phase 2, 1 Phase 3, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1
Phase 41Unknown 1

Follow Intranasal Dexmedetomidine: new trials by email Literature Review of Intranasal Dexmedetomidine trials Research Report on Intranasal Dexmedetomidine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
MInimizing Delirium With Nasal Dexmedetomidine-InducEd Sleep (MIDDIES)
Dexmedetomidine, Placebo - Major Abdominal Surgery, Postoperative Delirium (POD)
Phase 2 / Phase 3Not yet recruitingSixth Affiliated Hospital, Sun Yat-sen University4002026-05-012026-04-20
Intranasal Injection of Dexmedetomidine and Bupivacaine in Septoplasty Surgeries
Dexmedetomidine, Bupivacaine - Intranasal Dexmedetomidine, Intranasal Bupivacaine
Phase 4UnknownCairo University402019-07-202019-08-01

Narrower conditions

Emergence Delirium (1)  ·  Parasomnias (1)

Broader conditions

Confusion (1)  ·  Delirium (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurocognitive Disorders (1)  ·  Neurologic Manifestations (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Postoperative Complications (1)  ·  Signs and Symptoms (1)  ·  Sleep Wake Disorders (1)

Interventions

Dexmedetomidine (2)  ·  Bupivacaine (1)

Sponsors

Cairo University (1)  ·  Sixth Affiliated Hospital, Sun Yat-sen University (1)

Countries

Egypt (1)